Tiziana Life Sciences Plc Issue Of Convertible Loan Notes And Warrants Change Of Registered Office
6/17/2014 8:50:23 AM
London, 17 June 2014 - Tiziana Life Sciences plc (AIM: TILS) (the "Company"), a UK biotechnology company with a focus on therapeutic and diagnostic applications for cancer, is pleased to announce that the Company has issued £1,451,472 convertible loan notes ("Convertible Loan Notes"), which also carry warrants ("Warrants") to subscribe for an additional 1,995,774 ordinary shares of £0.03 each in the capital of the Company ("Ordinary Shares").
The Convertible Loan Notes carry interest at 6 per cent per annum payable in Ordinary Shares at the date of conversion. The Convertible Loan Notes and interest accrued thereon convert into Ordinary Shares at a conversion price of 24 pence per share and are restricted from conversion at any time before 28 March 2015.
The Warrants, which have been issued on the basis of 11 Warrants for each £8 of Convertible Loan Notes, contain a right to subscribe for Ordinary Shares at a price of 32 pence each and are restricted from exercise prior to 29 March 2015 and subsequent to 28 March 2017.
The proceeds from the issue of the Convertible Loan Notes will further strengthen the Company’s balance sheet and be used for the development of the Company’s intellectual property and for general working capital purposes.
The Company also confirms that it has changed its registered office address to 18 South Street, Mayfair, London W1K 1DG.
Tiziana Life Sciences PLC
44 (0)20 7493 2853
Help employers find you! Check out all the jobs and post your resume.
comments powered by